Michael N. VanSaun

2.0k total citations
41 papers, 1.6k citations indexed

About

Michael N. VanSaun is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Michael N. VanSaun has authored 41 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 15 papers in Molecular Biology and 14 papers in Cancer Research. Recurrent topics in Michael N. VanSaun's work include Pancreatic and Hepatic Oncology Research (10 papers), Protease and Inhibitor Mechanisms (7 papers) and Adipokines, Inflammation, and Metabolic Diseases (5 papers). Michael N. VanSaun is often cited by papers focused on Pancreatic and Hepatic Oncology Research (10 papers), Protease and Inhibitor Mechanisms (7 papers) and Adipokines, Inflammation, and Metabolic Diseases (5 papers). Michael N. VanSaun collaborates with scholars based in United States, India and South Korea. Michael N. VanSaun's co-authors include Lynn M. Matrisian, M. J. Werle, D. Lee Gorden, Alisha M. Mendonsa, Nipun B. Merchant, Nagaraj S. Nagathihalli, Jason Castellanos, J. Oliver McIntyre, In Kyu Lee and Xizi Dai and has published in prestigious journals such as PLoS ONE, Molecular and Cellular Biology and Cancer Research.

In The Last Decade

Michael N. VanSaun

39 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael N. VanSaun United States 22 721 500 359 350 176 41 1.6k
Guizhi Yang China 16 907 1.3× 261 0.5× 259 0.7× 292 0.8× 142 0.8× 29 1.6k
Lidia Villanova Italy 16 682 0.9× 390 0.8× 360 1.0× 306 0.9× 172 1.0× 17 1.4k
Yan Xia United States 16 750 1.0× 230 0.5× 406 1.1× 228 0.7× 197 1.1× 22 1.3k
Yi Luo China 24 895 1.2× 273 0.5× 499 1.4× 147 0.4× 174 1.0× 75 1.7k
Qingbin Kong China 15 1.0k 1.4× 364 0.7× 398 1.1× 168 0.5× 191 1.1× 17 1.7k
Tsuyoshi Ohta Japan 24 822 1.1× 408 0.8× 341 0.9× 112 0.3× 166 0.9× 68 1.7k
Esther Castaño Spain 20 856 1.2× 401 0.8× 376 1.0× 231 0.7× 157 0.9× 49 1.6k
Luca Gelsomino Italy 25 788 1.1× 465 0.9× 570 1.6× 277 0.8× 152 0.9× 52 1.5k
Kyung Song United States 22 1.1k 1.5× 341 0.7× 280 0.8× 164 0.5× 178 1.0× 50 1.6k
Sylvia Andrzejewski Canada 8 1.1k 1.6× 328 0.7× 703 2.0× 192 0.5× 231 1.3× 8 1.7k

Countries citing papers authored by Michael N. VanSaun

Since Specialization
Citations

This map shows the geographic impact of Michael N. VanSaun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael N. VanSaun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael N. VanSaun more than expected).

Fields of papers citing papers by Michael N. VanSaun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael N. VanSaun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael N. VanSaun. The network helps show where Michael N. VanSaun may publish in the future.

Co-authorship network of co-authors of Michael N. VanSaun

This figure shows the co-authorship network connecting the top 25 collaborators of Michael N. VanSaun. A scholar is included among the top collaborators of Michael N. VanSaun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael N. VanSaun. Michael N. VanSaun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Walsh, Ryan, et al.. (2025). Depletion of tumor-derived CXCL5 improves T cell infiltration and anti-PD-1 therapy response in an obese model of pancreatic cancer. Journal for ImmunoTherapy of Cancer. 13(3). e010057–e010057. 3 indexed citations
2.
Walsh, Ryan, et al.. (2025). Combined Omipalisib and MAPK Inhibition Suppress PDAC Growth. Cancers. 17(7). 1152–1152. 1 indexed citations
3.
Jain, Krishan Gopal, K. Venkateswara Swamy, Anup Kasi, et al.. (2023). Anticancer Activity of Novel Difluorinated Curcumin Analog and Its Inclusion Complex with 2-Hydroxypropyl-β-Cyclodextrin against Pancreatic Cancer. International Journal of Molecular Sciences. 24(7). 6336–6336. 12 indexed citations
4.
Chalise, Prabhakar, et al.. (2022). Abstract 4027: Dual MEK and AKT inhibition suppresses pancreatic cancer growth and migration. Cancer Research. 82(12_Supplement). 4027–4027. 2 indexed citations
5.
Dandawate, Prasad, et al.. (2022). SHP2 regulates adipose maintenance and adipocyte-pancreatic cancer cell crosstalk via PDHA1. Journal of Cell Communication and Signaling. 17(3). 575–590. 5 indexed citations
6.
Mehra, Siddharth, Supriya Srinivasan, Samara P. Singh, et al.. (2022). Urolithin A attenuates severity of chronic pancreatitis associated with continued alcohol intake by inhibiting PI3K/AKT/mTOR signaling. American Journal of Physiology-Gastrointestinal and Liver Physiology. 323(4). G375–G386. 12 indexed citations
7.
Manley, Sharon, et al.. (2022). Synthetic adiponectin-receptor agonist, AdipoRon, induces glycolytic dependence in pancreatic cancer cells. Cell Death and Disease. 13(2). 114–114. 20 indexed citations
8.
Willobee, Brent A., Austin R. Dosch, Jason Castellanos, et al.. (2021). Combined Blockade of MEK and CDK4/6 Pathways Induces Senescence to Improve Survival in Pancreatic Ductal Adenocarcinoma. Molecular Cancer Therapeutics. 20(7). 1246–1256. 25 indexed citations
9.
Totiger, Tulasigeri M., Supriya Srinivasan, Venkatakrishna R. Jala, et al.. (2018). Urolithin A, a Novel Natural Compound to Target PI3K/AKT/mTOR Pathway in Pancreatic Cancer. Molecular Cancer Therapeutics. 18(2). 301–311. 97 indexed citations
10.
Srinivasan, Supriya, Tulasigeri M. Totiger, Chanjuan Shi, et al.. (2018). Tobacco Carcinogen–Induced Production of GM-CSF Activates CREB to Promote Pancreatic Cancer. Cancer Research. 78(21). 6146–6158. 32 indexed citations
11.
Messaggio, Fanuel, Alisha M. Mendonsa, Jason Castellanos, et al.. (2017). Adiponectin receptor agonists inhibit leptin induced pSTAT3 and in vivo pancreatic tumor growth. Oncotarget. 8(49). 85378–85391. 51 indexed citations
12.
VanSaun, Michael N., E. Ashley Dozier, Kathy J. Carter, et al.. (2015). New tools for the quantitative assessment of prodrug delivery and neurotoxicity. NeuroToxicology. 47. 88–98. 4 indexed citations
13.
Barham, Whitney, Andrea L. Frump, Taylor P. Sherrill, et al.. (2013). Targeting the Wnt Pathway in Synovial Sarcoma Models. Cancer Discovery. 3(11). 1286–1301. 57 indexed citations
14.
VanSaun, Michael N.. (2013). Molecular Pathways: Adiponectin and Leptin Signaling in Cancer. Clinical Cancer Research. 19(8). 1926–1932. 184 indexed citations
15.
Lee, In Kyu, Michael N. VanSaun, Jung Ho Shim, Lynn M. Matrisian, & D. Lee Gorden. (2012). Increased metastases are associated with inflammation and matrix metalloproteinase-9 activity at incision sites in a murine model of peritoneal dissemination of colorectal cancer. Journal of Surgical Research. 180(2). 252–259. 25 indexed citations
16.
Gorden, D. Lee, Pavlina T. Ivanova, David S. Myers, et al.. (2011). Increased Diacylglycerols Characterize Hepatic Lipid Changes in Progression of Human Nonalcoholic Fatty Liver Disease; Comparison to a Murine Model. PLoS ONE. 6(8). e22775–e22775. 130 indexed citations
17.
Shaffer, Christian M., Maria P. Alfaro, Ashley Smith, et al.. (2011). Reprogramming of mesenchymal stem cells by the synovial sarcoma-associated oncogene SYT–SSX2. Oncogene. 31(18). 2323–2334. 54 indexed citations
18.
VanSaun, Michael N., In Kyu Lee, M. Kay Washington, Lynn M. Matrisian, & D. Lee Gorden. (2009). High Fat Diet Induced Hepatic Steatosis Establishes a Permissive Microenvironment for Colorectal Metastases and Promotes Primary Dysplasia in a Murine Model. American Journal Of Pathology. 175(1). 355–364. 110 indexed citations
19.
Welch, Danny R., Carlton R. Cooper, Douglas R. Hurst, et al.. (2008). Metastasis Research Society–American Association for Cancer Research Joint Conference on Metastasis. Cancer Research. 68(23). 9578–9582. 4 indexed citations
20.
Werle, M. J. & Michael N. VanSaun. (2003). Activity dependent removal of agrin from synaptic basal lamina by matrix metalloproteinase 3. Journal of Neurocytology. 32(5-8). 905–913. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guizhi Yang Breakdown of academic impact, for papers by Lidia Villanova Breakdown of academic impact, for papers by Yan Xia Breakdown of academic impact, for papers by Yi Luo Breakdown of academic impact, for papers by Qingbin Kong Breakdown of academic impact, for papers by Tsuyoshi Ohta Breakdown of academic impact, for papers by Esther Castaño Breakdown of academic impact, for papers by Luca Gelsomino Breakdown of academic impact, for papers by Kyung Song Breakdown of academic impact, for papers by Sylvia Andrzejewski
Rankless by CCL
2026